ArticleCureus2026
Unusual Presentation of Eumycetoma (Madura Foot): A Case Report.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Mycetoma, commonly referred to as Madura foot, is a chronic granulomatous infection of the skin and subcutaneous tissues caused by fungi (eumycetoma) or filamentous bacteria (actinomycetoma). It typically presents in the foot following traumatic inoculation in endemic regions. Extra-pedal presentations are uncommon and may pose diagnostic and therapeutic challenges. We present the case of a 21-year-old previously healthy male patient with an unusual eumycetoma involving the posterior chest wall (back), an atypical anatomical site. The diagnosis was initially suspected clinically due to the discharge of black grains from the lesion and was subsequently confirmed by cytology, fungal culture, and molecular sequencing, which identified Madurella mycetomatis. This case highlights the importance of considering mycetoma in chronic, indolent subcutaneous lesions, particularly in endemic areas, even when lesions arise outside the commonly affected sites.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.